Eikon Therapeutics has filed a notice of an exempt offering of securities to raise $534,999,983.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Eikon Therapeutics is raising $534,999,983.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Roger Perlmutter played a key role…